Literature DB >> 19124726

IL-12-dependent inducible expression of the CD94/NKG2A inhibitory receptor regulates CD94/NKG2C+ NK cell function.

Andrea Sáez-Borderías1, Neus Romo, Giuliana Magri, Mónica Gumá, Ana Angulo, Miguel López-Botet.   

Abstract

The inhibitory CD94/NKG2A and activating CD94/NKG2C killer lectin-like receptors specific for HLA-E have been reported to be selectively expressed by discrete NK and T cell subsets. In the present study, minor proportions of NK and T cells coexpressing both CD94/NKG2A and CD94/NKG2C were found in fresh peripheral blood from adult blood donors. Moreover, CD94/NKG2A surface expression was transiently detected upon in vitro stimulation of CD94/NKG2C+ NK cells in the presence of irradiated allogeneic PBMC or rIL-12. A similar effect was observed upon coculture of NKG2C+ NK clones with human CMV-infected autologous dendritic cell cultures, and it was prevented by an anti-IL-12 mAb. NKG2A inhibited the cytolytic activity of NKG2C+ NK clones upon engagement either by a specific mAb or upon interaction with a transfectant of the HLA class I-deficient 721.221 cell line expressing HLA-E. These data indicate that beyond its constitutive expression by an NK cell subset, NKG2A may be also transiently displayed by CD94/NKG2C+ NK cells under the influence of IL-12, providing a potential negative regulatory feedback mechanism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19124726     DOI: 10.4049/jimmunol.182.2.829

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

1.  Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection.

Authors:  Sandra Lopez-Vergès; Jeffrey M Milush; Brian S Schwartz; Marcelo J Pando; Jessica Jarjoura; Vanessa A York; Jeffrey P Houchins; Steve Miller; Sang-Mo Kang; Phillip J Norris; Douglas F Nixon; Lewis L Lanier
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

2.  Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells.

Authors:  Takahiro Kamiya; See Voon Seow; Desmond Wong; Murray Robinson; Dario Campana
Journal:  J Clin Invest       Date:  2019-03-12       Impact factor: 14.808

3.  In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target.

Authors:  Robert T Manguso; Hans W Pope; Margaret D Zimmer; Flavian D Brown; Kathleen B Yates; Brian C Miller; Natalie B Collins; Kevin Bi; Martin W LaFleur; Vikram R Juneja; Sarah A Weiss; Jennifer Lo; David E Fisher; Diana Miao; Eliezer Van Allen; David E Root; Arlene H Sharpe; John G Doench; W Nicholas Haining
Journal:  Nature       Date:  2017-07-19       Impact factor: 49.962

4.  Chronic alcohol consumption enhances iNKT cell maturation and activation.

Authors:  Hui Zhang; Faya Zhang; Zhaohui Zhu; Dung Luong; Gary G Meadows
Journal:  Toxicol Appl Pharmacol       Date:  2014-12-09       Impact factor: 4.219

5.  NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs.

Authors:  Vivien Béziat; Benjamin Descours; Christophe Parizot; Patrice Debré; Vincent Vieillard
Journal:  PLoS One       Date:  2010-08-06       Impact factor: 3.240

6.  Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology.

Authors:  Junwei Hao; Ruolan Liu; Wenhua Piao; Qinghua Zhou; Timothy L Vollmer; Denise I Campagnolo; Rong Xiang; Antonio La Cava; Luc Van Kaer; Fu-Dong Shi
Journal:  J Exp Med       Date:  2010-08-09       Impact factor: 14.307

7.  miR-146a negatively regulates NK cell functions via STAT1 signaling.

Authors:  Dongqing Xu; Qiuju Han; Zhaohua Hou; Cai Zhang; Jian Zhang
Journal:  Cell Mol Immunol       Date:  2016-03-21       Impact factor: 11.530

8.  Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner.

Authors:  Golo Ahlenstiel; Rachel H Titerence; Christopher Koh; Birgit Edlich; Jordan J Feld; Yaron Rotman; Marc G Ghany; Jay H Hoofnagle; T Jake Liang; Theo Heller; Barbara Rehermann
Journal:  Gastroenterology       Date:  2009-09-10       Impact factor: 22.682

Review 9.  Bi-specific and Tri-specific NK Cell Engagers: The New Avenue of Targeted NK Cell Immunotherapy.

Authors:  Shee Kwan Phung; Jeffrey S Miller; Martin Felices
Journal:  Mol Diagn Ther       Date:  2021-07-29       Impact factor: 4.074

10.  Modulation of the inhibitory receptor leukocyte Ig-like receptor 1 on human natural killer cells.

Authors:  Nicholas L Li; Chelsea L Davidson; Atul Humar; Deborah N Burshtyn
Journal:  Front Immunol       Date:  2011-09-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.